On October 26, 2017 Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, reported that it plans to host a conference call and webcast on Monday, November 6, 2017 at 5:00 p.m. ET to discuss its third quarter 2017 financial results and provide a corporate update (Press release, Keryx Biopharmaceuticals, OCT 26, 2017, View Source [SID1234521215]).

To participate in the conference call, please dial 1-888-396-2320 (U.S.), 1-774-264-7560 (international) and refer to conference ID: 2193619. The call will be webcast live with slides and accessible through the Investors section of the company’s website at www.keryx.com for a period of 15 days after the call.